Methods and compositions for treating tumors and metastatic disease

Details for Australian Patent Application No. 2005213324 (hide)

Owner Elan Pharmaceuticals, Inc.

Inventors Wehner, Nancy

Agent Mallesons

Pub. Number AU-B-2005213324

PCT Pub. Number WO2005/076843

Priority 60/541,946 06.02.04 US

Filing date 3 February 2005

Wipo publication date 25 August 2005

Acceptance publication date 9 June 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/02 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

Event Publications

17 August 2006 PCT application entered the National Phase

  PCT publication WO2005/076843 Priority application(s): WO2005/076843

9 June 2011 Application Accepted

  Published as AU-B-2005213324

6 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005213326-Compositions and methods relating to culturing neural stem cells with bone marrow stromal cells

2005213318-Method for detection of promoter methylation status